On December 31, 2019, a cluster of pneumonia cases of unknown origin was reported in the city of Wuhan; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was then discovered as the causative agent of the espiratory disease named coronavirus disease 2019 (COVID-19). The epidemic spread rapidly through China and subsequently to the rest of the world, leading the World Health Organization to declare the pandemic state on March 11, 2020. COVID-19 has caused a global impact on public health services that led to the reorganization of hospital settings, including in-office visits for patients with cardiac implantable electronic device (CIED). Remote monitoring (RM) of CIED patients represents an appropriate strategy to minimize any potential risk of virus exposure for patients and health care providers, without compromising the quality of care. RM offers access to the same information as an in-office visit and may contribute to the early detection of atrial and ventricular arrhythmias prevent heart failure (HF) decompensation, and manage device-related issues. RM has also confirmed its usefulness in decreasing the hospitalization rate and improving clinical outcomes. Moreover, since the onset of the COVID-19 pandemic, physicians have suspended nonurgent scheduled visits and made a rapid transition to virtual visits (VV). Thanksto the technological improvement, patients utilizing wearable sensors for the measurement of hemodynamic parameters (blood pressure and saturation, heart rate) and adopting virtual health platforms may be monitored directly from home without any risk of infection. In this review, we provide an overview of the many possible applications of RM, its limitations and challenges in patients with CIED during the COVID-19 pandemic

Impact of COVID-19 Pandemic on Cardiac Electronic Device Management and Role of Remote Monitoring / Magnocavallo, Michele; Vetta, Giampaolo; Bernardini, Alessia; Piro, Agostino; Mei, Maria Chiara; Di Iorio, Martina; Mariani, Marco Valerio; Della Rocca, Domenico G.; Severino, Paolo; Quaglione, Raffaele; Giunta, Giuseppe; Chimenti, Cristina; Miraldi, Fabio; Vizza, Carmine Dario; Fedele, Francesco; Lavalle, Carlo. - In: CARDIAC ELECTROPHYSIOLOGY CLINICS. - ISSN 1877-9182. - 14:1(2022), pp. 125-131. [10.1016/j.ccep.2021.10.010]

Impact of COVID-19 Pandemic on Cardiac Electronic Device Management and Role of Remote Monitoring

Magnocavallo, Michele;Bernardini, Alessia;Piro, Agostino;Mei, Maria Chiara;Di Iorio, Martina;Mariani, Marco Valerio;Severino, Paolo;Quaglione, Raffaele;Giunta, Giuseppe;Chimenti, Cristina;Miraldi, Fabio;Vizza, Carmine Dario;Fedele, Francesco;Lavalle, Carlo
2022

Abstract

On December 31, 2019, a cluster of pneumonia cases of unknown origin was reported in the city of Wuhan; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was then discovered as the causative agent of the espiratory disease named coronavirus disease 2019 (COVID-19). The epidemic spread rapidly through China and subsequently to the rest of the world, leading the World Health Organization to declare the pandemic state on March 11, 2020. COVID-19 has caused a global impact on public health services that led to the reorganization of hospital settings, including in-office visits for patients with cardiac implantable electronic device (CIED). Remote monitoring (RM) of CIED patients represents an appropriate strategy to minimize any potential risk of virus exposure for patients and health care providers, without compromising the quality of care. RM offers access to the same information as an in-office visit and may contribute to the early detection of atrial and ventricular arrhythmias prevent heart failure (HF) decompensation, and manage device-related issues. RM has also confirmed its usefulness in decreasing the hospitalization rate and improving clinical outcomes. Moreover, since the onset of the COVID-19 pandemic, physicians have suspended nonurgent scheduled visits and made a rapid transition to virtual visits (VV). Thanksto the technological improvement, patients utilizing wearable sensors for the measurement of hemodynamic parameters (blood pressure and saturation, heart rate) and adopting virtual health platforms may be monitored directly from home without any risk of infection. In this review, we provide an overview of the many possible applications of RM, its limitations and challenges in patients with CIED during the COVID-19 pandemic
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1634115
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? ND
social impact